BEAM vs HAS · rev $63.5M vs P/E 25, rev $4.75B
Beam Therapeutics Inc (BEAM) versus Hasbro Inc (HAS) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Hasbro Inc (HAS) is a leisure company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
BEAM currently screens at market cap $2.01B. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Not investment advice. Open the BEAM and HAS stock pages for the full models.
Not investment advice.